HIGHLIGHTS
- who: Ernesto Rossi and colleagues from the Medical Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy have published the Article: Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients, in the Journal: Cancers 2023, 493 of 13/01/2023
- what: This study shows that the addition of hepatic radiotherapy to anti-PD-1 treatment can be a valid option for the treatment of metastatic uveal melanoma particularly for HLA A 02:01 negative patients. This study has also demonstrated a correlation between tumor control and survival. The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.